Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. HOTH
HOTH logo

HOTH

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

HOTH News

NASA Chief Warns of Uncertain Commercial Demand in Space Economy

3d agostocktwits

NASA Chief Warns of Uncertain Commercial Demand in Space Economy

3d agoYahoo Finance

Hoth Transforms into Rocket One, Shares Surge 80%

3d agostocktwits

Hoth Therapeutics Rebrands to Rocket One, Adopts New Ticker RKTO

3d agoPRnewswire

Hoth Therapeutics Secures Patent Allowance for HT-KIT Program

4d agoPRnewswire

Hoth Therapeutics Secures Patent Allowance for HT-KIT Program

4d agoNewsfilter

Hoth Rebrands to Rocket One, Targets AI Semiconductor Market

May 19 2026PRnewswire

Spain Approves Hoth's Clinical Trial for HT-001

May 05 2026PRnewswire

Hoth Therapeutics Shares Surge 55% on Positive HT-VA Study Results

Apr 14 2026NASDAQ.COM

REPL Faces Pressure After FDA Issues Second Complete Response Letter

Apr 14 2026stocktwits

HT-VA Drug Outperforms Novo Nordisk in Key Metabolic Markers

Apr 14 2026stocktwits

GDNF Shows Promise as Next-Gen Therapy for MAFLD and Obesity

Apr 13 2026PRnewswire

GDNF Shows Promise as Next-Gen Therapy for MAFLD and Obesity

Apr 13 2026Newsfilter

Hoth Therapeutics Closes Registered Direct Offering

Apr 02 2026PRnewswire

Hoth Therapeutics Secures $2 Million Financing Through Share Offering

Apr 02 2026NASDAQ.COM

Hoth Therapeutics Announces Stock Offering and Warrants Sale

Apr 01 2026Newsfilter